参考文献/References:
［1］BROSENS I, GORDTS S, HABIBA M, et al. Uterine cystic adenomyosis: a disease of younger women ［J］. Journal of Pediatric and Adolescent Gynecology, 2015, 28(6): 420-426.
［2］Attaran M, Falcone T. Adolescent endometriosis ［J］. Journal of Minimally Invasive Gynecology，2015, 22(5):705-706.
［3］ITAM S P,Ayensu-Coker L,sanchez J et al. Adenomyosis in the adolescent population:a case report and review of the literature ［J］. Journal of Pediatric and Adolescent Gynecology, 2009, 22(5): e 146-e 147.
［4］VITONIS A F, BAER H J, HANKINSON S E, et al. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis ［J］. Human Reproduction, 2010, 25(5): 1325-1334.
［5］FERRERO S, VENTURINI P L, RAGNI N, et al. Pharmacological treatment of endometriosis experience with aromatase inhibitors ［J］. Drugs, 2009, 69(8): 943-952.
［6］TAKEUCHI H, KITADE M, KIKUCHI I, et al. And histopathologic findings of juvenile cystic adenomyoma:a review of nine cases ［J］. Fertility and Sterility, 2010, 94(3): 862-868.
［7］BALLWEG M L. Big picture of endometriosis helps provide guidance on approach to teens:comparative historical data show endo starting younger,is more severe ［J］. Journal of Pediatric and Adolescent Gynecology, 2003, 16(3 Suppl): S 21-S 26.
［8］Garcia-Solares J, Donnez J, Donnez O, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? ［J］Fertility and Sterility，2018, 109(3):371-379.
［9］DUEHOLM M, LUNDORF E. Transvaginal ultrasound or MRI for diagnosis of adenornyosis ［J］. Current Opinion in Obstetrics & Gynecology, 2007, 19(6): 505-512.
［10］LIU X, DING D, REN Y, et al. Transvaginal elastosonography as an imaging technique for diagnosing adenomyosis ［J］. Reproductive Sciences, 2018, 25(4): 498-514.
［11］SANFILIPPO J S, WAKIM N G, SCHIKLER K N, et al. Endometriosis in association with uterine anomaly ［J］. American Journal of Obstetrics and Gynecology, 1986, 154(1): 39-43.
［12］KHAN K N, KITAJIMA M, HIRAKI K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy ［J］. Human Reproduction (Oxford, England), 2010, 25(3): 642-653.
［13］DIETRICH J E. An update on adenomyosis in the adolescent ［J］. Current Opinion in Obstetrics & Gynecology, 2010, 22(5): 388-392.
［14］Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery［J］. The Cochrane database of systematic reviews， 2004(3):CD003678-CD003678.
［15］VANNUCCINI S, LUISI S, TOSTI C, et al. Role of medical therapy in the management of uterine adenomyosis ［J］. Fertility and Sterility, 2018, 109(3): 398-405.
［16］PROPST A M, LAUFER M R. Endometriosis in adolescents—— Incidence, diagnosis and treatment ［J］. Journal of Reproductive Medicine, 1999, 44(9): 751-758.
［17］American College of Obstetricicans & Gynecologists. ACOG Committee Opinion. Number 310, April 2005. Endometriosis in adolescents ［J］. Obstetrics and Gynecology,2005, 105(4):921-927.
［18］DIVASTA A D, LAUFER M R, GORDON C M. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis ［J］. Journal of Pediatric and Adolescent Gynecology, 2007, 20(5): 293-297.
［19］BEDAIWY M A, MOUSA N A, CASPER R F. Aromatase inhibitors: potential reproductive implications ［J］. Journal of Minimally Invasive Gynecology, 2009, 16(5): 533-539.
［20］NIE Ji-chan, LIU Xi-shi, GUO Sun-wei. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent ［J］. Reproductive Sciences, 2010, 17(11): 995-1005.
［21］Nie J, Liu X, Lu Y, et al: Immunoreactivity of progesterone recpetor isoform B (PR-B), nuclear factor-kappa B (NF-kappa B) and I kappa B alpha in Adenomyosis ［J］. Reproductive Sciences，2009, 16(3):133A.
［22］LIU Xi-shi, YUAN Lei, GUO Sun-wei. Valproic acid as a therapy for adenomyosis: a comparative case series ［J］. Reproductive Sciences, 2010, 17(10): 904-912.
［23］LIU X, NIE J, GUO S-w. Elevated immunoreactivity against class I histone deacetylases in adenomyosis ［J］. Gynecologic and Obstetric Investigation, 2012, 74(1): 50-55.
［24］LIU X, GUO S-w. A pilot study on the off-label use of valproic acid to treat adenomyosis ［J］. Fertility and Sterility, 2008, 89(1): 246-250.
［25］GUO S-w, DING D, LIU X. Anti-platelet therapy is efficacious in treating endometriosis induced in mouse ［J］. Reproductive BioMedicine Online, 2016, 33(4): 484-499.
［26］SUN A-j, LUO M, WANG W, et al. Lang J-h:characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma ［J］. Chinese Medical Journal, 2011, 124(9): 1322-1326.
［27］SAREMI A, BAHRAMI H, SALEHIAN P, et al. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique ［J］. Reproductive BioMedicine Online, 2014, 28(6): 753-760.
［28］YOUNES G, TULANDI T. Conservative surgery for adenomyosis and results: a systematic review ［J］. Journal of Minimally Invasive Gynecology, 2018, 25(2): 265-276.
［29］OSADA H. Uterine adenomyosis and adenomyoma: the surgical approach ［J］. Fertility and Sterility, 2018, 109(3): 406-417.